Evidence map›Paper›PMID 29361519›Full record

ArticleDisease models & mechanisms2018

Curcumin and derivatives function through protein phosphatase 2A and presenilin orthologues in

Marco Cocorocchio, Amy J Baldwin, Balint Stewart, Lou Kim, Adrian J Harwood, Christopher R L Thompson, Paul L R Andrews, Robin S B Williams

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Pharmacological inhibition of ENT1 enhances the impact of specific dietary fats on energy metabolism gene expression.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Cells · 2022
    Review
  9. Dictyostelium discoideum: An Alternative Nonanimal Model for Developmental Toxicity Testing.Toxicological sciences : an official journal of the Society of Toxicology · 2021
    Article
  10. TheFrontiers in cell and developmental biology · 2021
    Review
  11. Review
  12. UsingFrontiers in cell and developmental biology · 2021
    Review
  13. Decanoic acid inhibits mTORC1 activity independent of glucose and insulin signaling.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  14. ABiochemistry and biophysics reports · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Marco CocorocchioCentre of Biomedical Sciences, School of Biological Sciences, Royal Holloway University of London, Egham, TW20 0EX UK.
Amy J BaldwinNeuroscience and Mental Health Research Institute, Cardiff University, CF24 4HQ, UK.
Balint StewartDepartment of Genetics, Evolution and Environment, University College London, Darwin Building, Gower Street, London WC1E 6BT, UK.
Lou KimDepartment of Biological Sciences, Florida International University, Miami, Florida International University, Miami, FL 33199, USA.
Adrian J HarwoodNeuroscience and Mental Health Research Institute, Cardiff University, CF24 4HQ, UK.
Christopher R L ThompsonDepartment of Genetics, Evolution and Environment, University College London, Darwin Building, Gower Street, London WC1E 6BT, UK.
Paul L R AndrewsDivision of Biomedical Science, St George's University of London, SW17 0RE, UK.
Robin S B WilliamsCentre of Biomedical Sciences, School of Biological Sciences, Royal Holloway University of London, Egham, TW20 0EX UK robin.williams@rhul.ac.uk.ORCID 0000-0002-9826-6020
Cardiff University · GBRoyal Holloway University of London · GBUniversity College London · GBFlorida International University · USSt George's, University of London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/M007146/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/M001504/1Wellcome Trust 101582Z/13/Z
6 · The paper itself

Abstract

Natural compounds often have complex molecular structures and unknown molecular targets. These characteristics make them difficult to analyse using a classical pharmacological approach. Curcumin, the main curcuminoid of turmeric, is a complex molecule possessing wide-ranging biological activities, cellular mechanisms and roles in potential therapeutic treatment, including Alzheimer's disease and cancer. Here, we investigate the physiological effects and molecular targets of curcumin in

Indexed as

Sequence Homology, Amino AcidAntioxidantsCurcuminDictyosteliumLigandsMolecular Docking SimulationPresenilin-1Protein Phosphatase 2AntioxidantsCurcuminLigandsPresenilin-1Protein Phosphatase 2Alzheimer's diseaseCancerCurcuminDictyostelium discoideumPP2APresenilin

Identifiers

PMID29361519
PMCPMC5818083
OpenAlexW2778995150

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.